Jun 30, 2026
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.91 to $0.05.
The split itself did not change the total investment value.
Quince Therapeutics, Inc. (QNCX) trades on the NASDAQ Global Select in the Biotechnology industry.
Quince Therapeutics, Inc. company overviewThe latest split shown was on June 30, 2026. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 2 reverse splits between April 13, 2026 and June 30, 2026.